Evidence map›Paper›PMID 40130143›Full record

ArticleCureus2025

Treatment of Primary Pulmonary Synovial Sarcoma in a Low-Resource Country: A Case Report.

Araksi Gasparyan, Tatul Saghatelyan, Sergey Abrahamyan, Narek Shaverdian, Sergo Mkhitaryan

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Araksi GasparyanDepartment of Oncology, Yerevan State Medical University, Yerevan, ARM.
Tatul SaghatelyanDepartment of Radiation Oncology, National Center of Oncology, Yerevan, ARM.
Sergey AbrahamyanDepartment of Thoracic Surgery, National Center of Oncology, Yerevan, ARM.
Narek ShaverdianDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York City, USA.
Sergo MkhitaryanDepartment of Radiation Oncology, National Center of Oncology, Yerevan, ARM.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary synovial sarcoma of the lung is a rare malignant cancer. The symptoms are nonspecific; they may not appear at all, so it is often diagnosed in the late stages. Moreover, accurate diagnosis requires a combination of the results of clinical evaluation, imaging, and histological examinations, since the results of these methods separately are not very specific and may lead to misdiagnosis. Given the rarity of this diagnosis, the therapy is not standardized. The preferred treatment regimen involves surgery combined with neoadjuvant or adjuvant radio- and chemotherapy. This case report describes a 67-year-old male patient who was diagnosed with pulmonary synovial sarcoma. Diagnosis was confirmed via computed tomography (CT) imaging and immunohistochemical (IHC) examination. After surgical removal, the patient underwent adjuvant radiotherapy.

Indexed as

adjuvant radiotherapycase reportlung cancersynovial sarcomathoracic surgery

Identifiers

PMID40130143
PMCPMC11932500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.